Alerts will be sent to your verified email
Verify Email3BBLACKBIO
3B Blackbio Dx
|
TTK Healthcare
|
Nureca Ltd.
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
31.8 % | 21.34 % | 17.64 % |
5yr average Equity Multiplier
|
1.27 | 1.49 | 1.35 |
5yr Average Asset Turnover Ratio
|
0.56 | 0.97 | 1.22 |
5yr Avg Net Profit Margin
|
40.4 % | 23.04 % | 7.28 % |
Price to Book
|
6.18 | 1.67 | 1.3 |
P/E
|
31.72 | 20.72 | 0.0 |
5yr Avg Cash Conversion Cycle
|
152.2 Days | -31.94 Days | 99.45 Days |
Inventory Days
|
35.71 Days | 43.46 Days | 87.15 Days |
Days Receivable
|
172.8 Days | 41.18 Days | 10.79 Days |
Days Payable
|
58.4 Days | 113.69 Days | 28.67 Days |
5yr Average Interest Coverage Ratio
|
328.3 | 14.83 | 21.65 |
5yr Avg ROCE
|
38.24 % | 7.45 % | 20.09 % |
5yr Avg Operating Profit Margin
|
47.2 % | 4.27 % | 7.14 % |
5 yr average Debt to Equity
|
0.03 | 0.06 | 0.13 |
5yr CAGR Net Profit
|
33.12 % | 38.52 % | n/a |
5yr Average Return on Assets
|
23.56 % | 16.02 % | 11.23 % |
Shareholdings
|
|||
Promoter Holding
|
41.28 % | 74.56 % | 64.3 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
2.85 % | 0.0 | -5.7 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.39 % | -1.35 % |
3B Blackbio Dx
|
TTK Healthcare
|
Nureca Ltd.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|